Bonbrrin en es it fr

Bonbrrin Brand names, Bonbrrin Analogs

Bonbrrin Brand Names Mixture

  • No information avaliable

Bonbrrin Chemical_Formula


Bonbrrin RX_link

Bonbrrin fda sheet

Bonbrrin FDA

Bonbrrin msds (material safety sheet)

Bonbrrin Synthesis Reference

No information avaliable

Bonbrrin Molecular Weight

387.711 g/mol

Bonbrrin Melting Point

No information avaliable

Bonbrrin H2O Solubility

No information avaliable

Bonbrrin State


Bonbrrin LogP


Bonbrrin Dosage Forms

Cream; Ointment; Suppository (each applicator-full provides approximately 4.6 grams of ointment containing 300 mg of tioconazole)

Bonbrrin Indication

For the local treatment of vulvovaginal candidiasis (moniliasis).

Bonbrrin Pharmacology

Tioconazole is a broad-spectrum imidazole antifungal agent that inhibits the growth of human pathogenic yeasts. Tioconazole exhibits fungicidal activity in vitro against Candida albicans, other species of the genus Candida, and against Torulopsis glabrata. Tioconazole prevents the growth and function of some fungal organisms by interfering with the production of substances needed to preserve the cell membrane. This drug is effective only for infections caused by fungal organisms. It will not work for bacterial or viral infections.

Bonbrrin Absorption

Systemic absorption following a single intravaginal application of tioconazole in nonpregnant patients is negligible.

Bonbrrin side effects and Toxicity

Symptoms of overdose include erythema, stinging, blistering, peeling, edema, pruritus, urticaria, burning,

Bonbrrin Patient Information

Bonbrrin Organisms Affected

Yeast and other fungi